INVSENSOR00063

· Masimo Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INVSENSOR00063, covering 2023-07-10 to 2023-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts [NA]